Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Cash Flow Performance
Above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$2.77B
↑ 33% above average
Average (7y)
$2.08B
Historical baseline
Range
High:$2.99B
Low:$1.42B
CAGR
+10.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.77B | -7.3% |
| 2023 | $2.99B | +39.4% |
| 2022 | $2.14B | +6.3% |
| 2021 | $2.02B | -0.8% |
| 2020 | $2.03B | +22.0% |
| 2019 | $1.67B | +3.0% |
| 2018 | $1.62B | +14.1% |
| 2017 | $1.42B | - |